Search

everythinglearnresearchcommunity

for

Search:↓

3α-AdiolG is a good marker for androgen activity in women with excessive hair growth and decreases with anti-androgen treatment.

Women also use 5α-reductase inhibitors for hair loss and hirsutism.

Finasteride lowers DHT levels and raises testosterone in a dose-dependent way.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

5α-reductase deficiency can cause ambiguous genitalia and gender dysphoria, treatable with testosterone.

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.

Genetic differences within ethnic groups may affect prostate cancer treatment effectiveness.

Consider rare forms of CAH for accurate diagnosis and treatment.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Women with hyperandrogenism have higher androgen levels and lower SHBG, which may contribute to conditions like excessive hair growth and early puberty.

Dutasteride may reduce insulin sensitivity and increase body fat.

Blocking 11β-HSD1 reduces stress hormone damage in hair growth cells.

Anabolic steroids and inflammation can disrupt androgen metabolism, potentially causing health issues.

The enzyme system in hair follicles is similar to the liver's and is affected by certain inhibitors.

New A-homo-B, 19-dinor steroids showed strong antiandrogenic activity without affecting the enzyme 5α-reductase or androgen receptor binding.

Androgenetic alopecia in males is linked to hormone levels and the enzyme 5-alpha reductase.

Finasteride modifies 5-alpha-reductases through a two-step process, affecting inhibitor potency and possibly causing side effects.

Testosterone and its metabolites affect brain functions and could help treat neurological disorders.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

The new compound may be a safer alternative to finasteride for prostate protection.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

Men with male-pattern baldness have higher levels of certain testosterone metabolites and may have more active androgen metabolism.

5α-reductase inhibitors like finasteride and dutasteride effectively treat BPH by reducing DHT levels.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

Compound 4 is a promising treatment for hair loss with low toxicity.

The new compounds may be more effective and cheaper than current treatments for conditions like baldness.